Cargando…
Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues
The MLKL pseudokinase is the terminal effector in the necroptosis cell death pathway. Phosphorylation by its upstream regulator, RIPK3, triggers MLKL’s conversion from a dormant cytoplasmic protein into oligomers that translocate to, and permeabilize, the plasma membrane to kill cells. The precise m...
Autores principales: | Davies, Katherine A., Fitzgibbon, Cheree, Young, Samuel N., Garnish, Sarah E., Yeung, Wayland, Coursier, Diane, Birkinshaw, Richard W., Sandow, Jarrod J., Lehmann, Wil I. L., Liang, Lung-Yu, Lucet, Isabelle S., Chalmers, James D., Patrick, Wayne M., Kannan, Natarajan, Petrie, Emma J., Czabotar, Peter E., Murphy, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305131/ https://www.ncbi.nlm.nih.gov/pubmed/32561735 http://dx.doi.org/10.1038/s41467-020-16823-3 |
Ejemplares similares
-
Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization
por: Meng, Yanxiang, et al.
Publicado: (2023) -
Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis
por: Garnish, Sarah E., et al.
Publicado: (2021) -
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis
por: Petrie, Emma J., et al.
Publicado: (2018) -
Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis
por: Meng, Yanxiang, et al.
Publicado: (2021) -
The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation
por: Xu, Haixia, et al.
Publicado: (2019)